Poster Abstract Session:
143. Hepatitis Viruses
Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:

-

Tracks: Adult ID, Investigative ID

Presentations:
1024
Expanding primary care treatment of hepatitis C through telemedicine
Sheila Montalvo, PharmD ; Elizabeth Sherman, PharmD, AAHIVP ; Paula Eckardt, MD ; Angela Savage, RN ; Dushyantha Jayaweera, MD, MRCOG, FACP ; Jeffrey Beal, MD
Posters
  • IDSA HCV Poster .pdf (277.8 kB)
    • 1025
    Treatment Outcomes Using Boceprevir or Telaprevir in the University of Washington Project ECHO HCV Cohort
    Sophie Woolston, M.D. ; John Scott, MD, FIDSA
    1027
    Identification of Patient Factors Associated with Hepatitis C Treatment Failure in a Pharmacist Managed Hepatitis C Program
    Farah Barada, PharmD ; Lana Gerzenshtein, PharmD ; Michael Postelnick, RPh ; Hannah Brooks, PharmD ; Milena Mclaughlin, PharmD, MSc
    Posters
  • HCV Tx Failure ID Week Poster_FINAL.pdf (405.8 kB)
    • 1028
    Early Treatment Results for Interferon-free Hepatitis Treatment Regimens
    Sandra Kaminski, MS, PA-C ; Kendra Vermeulen, Pharm.D., AAHIVP ; Sharon Morgan, APN ; Nancy Celander, RPH ; Robert H K Eng, MD
    1029
    Impact of Interferon-Era HCV Treatment Contraindications on Current Referral and Treatment Trends
    Larissa Muething, MD ; Edward M. Gardner, MD ; Rebecca Hanratty, MD ; Aimee Truesdale, MD ; Sarah Rowan, MD
    Posters
  • Muething IDSA poster v5.pdf (388.2 kB)
    • 1030
    Adverse events (AE) and laboratory changes in a real-world population of Hepatitis C Virus (HCV)-infected patients with chronic kidney disease (CKD) treated with sofosbuvir (SOF)-based therapy
    Elke Backman, PharmD ; Guillermo Ortiz, MD ; Gregory Hundemer, MD ; Nneka Ufere, MD ; Raymond Chung, MD ; Meghan Sise, MD MS
    Posters
  • HCV poster 1030.pdf (519.3 kB)
    • 1031
    Efficacy of intervention to increase Hepatitis C screening in a community hospital
    Uri Goldberg, MD ; David Biobaku, MD ; Malik Malik, MD ; Angela Belfer, RN ; Muhammad Hasan, MD ; Sibte Burney, MD
    1032
    HCV Cascade of Care in A Single Veteran’s Affairs Medical Center
    Debika Bhattacharya, MD, MSc ; Hemen Saifu, MPH ; Tuyen Hoang, PhD ; William a. Schwartzman, M.D. ; Alan Sheinbaum, MD ; Pamela Belperio, PharmD ; Matthew Bidwell Goetz, MD
    1033
    Exploring the Benefits of an Enhanced Social Work Intervention within the HCV Cascade of Care
    Sean Patterson, MSW, LGSW ; Alexander Geboy, MS ; Tammy Cha, MSW, LGSW ; Adebisi Ayodele, NP ; Idene Perez, . ; Dawn Fishbein, MD, MS
    Posters
  • Enhanced SW HCV poster ID Week.pdf (1.4 MB)
    • 1034
    IL28B is Predictive of Spontaneous Postpartum Clearance of Chronic Hepatitis C Virus Infection in Pregnant women
    Mohamed Hashem, MBBCh, MSc ; Samer El-Kamary, MBChB, MS, MPH ; Ravi Jhaveri, MD, FIDSA, FPIDS ; Doa'a Saleh, MBBCh, MSc, MD ; Mohamed Ehab, MBBCh, MSc, MD ; Sahar Sharaf, MBBCh, MSc, MD ; Fatma El-Mougy, MBBCh, MSc, MD ; Lobna Abdelsalam, MBBCh, MSc ; Ahmed Aboulnasr, MBBCh, MSc, MD ; Hesham El-Ghazaly, MBBCh, MSc, MD
    Posters
  • IDWeek_2015_Presentation no. 1034 [M. Hashem].pdf (99.8 kB)
    • 1035
    Diagnosed, staged and untreated:  Hepatitis C fibrosis severity by transient elastography (TE) in an inner city clinic
    Oluwatoyin Adeyemi, MD ; Benjamin Go, MD ; Anna Hotton, PhD, MPH ; Maureen Gallagher, NP ; Deborah Wolen, NP ; Rebecca Goldberg, RN ; Crystal Winston, BA ; Dan Taussig, MPH ; Sonia Vibhakar, PharmD ; Gregory Huhn, MD, MPHTM
    Posters
  • IDweek2015POSTERBETTERFINAL.pdf (878.2 kB)
    • 1036
    Gender, Ethnicity, Intravenous Drug Use, and Risk for Hepatitis C Among New York City Jail inmates
    Matthew Akiyama, MD, MSc ; Fatos Kaba, MA ; Zachary Rosner, MD ; Robert Holzman, MD, FIDSA, FSHEA ; Ross Macdonald, MD
    Posters
  • IDSA Poster 1036 - Final.pdf (339.3 kB)
    • 1037
    Hepatitis C Virus (HCV) In Young Suburban Heroin Users In New Jersey; Part Of The Second Wave Of Hepatitis C
    Ronald Nahass, MD, FIDSA, FSHEA ; Kathleen Seneca, MSN, APN ; Serra Akyar, MPH ; Neal Schofield, MD, FAPA ; Mark Schwartz, MD, FAAFP, FASAM
    Posters
  • HCV Princeton House final.pdf (399.2 kB)
    • 1038
    Linkage to Care for Hepatitis C: Creating a Cascade of Care to Identify Gaps at the Individual Hospital Level
    Asher Schranz, MD ; Jason Halperin, MD, MPH ; Andrea Liu, BA ; Henry Lee, BS ; Harold Horowitz, MD ; Ellie Carmody, MD
    Posters
  • HCV Cascade-Linkage Poster 1038.pdf (2.2 MB)
    • 1039
    Improving Estimation of the Prevalence of Hepatitis C in the United States
    Benjamin Eckhardt, MD ; Marla Shu, MD ; Scott D. Holmberg, MD, MPH, FIDSA ; Tracy Swan ; Brian R. Edlin, MD
    Posters
  • IDSA poster.pdf (931.8 kB)
    • 1040
    Hepatitis C Surveillance Markers Study: A Validation of Genotype as a Laboratory Proxy for Linkage to Care
    Jason Halperin, MD, MPH ; Asher Schranz, MD ; Fabienne Laraque, MD, MPH ; Katherine Bornschlegel, MPH ; Emily Mcgibbon, MPH ; Harold Horowitz, MD ; Ellie Carmody, MD
    Posters
  • HCV Surveillance Marker Study - _Final draft.pdf (493.2 kB)
    • 1042
    Hepatitis C Risk Factors in a Cambodian American Population in Lowell, Massachusetts
    Catherine Yu, MD ; Allen Gifford, MD ; Cindy L. Christiansen, Ph.D. ; Mari-Lynn Drainoni, MEd, PhD
    Posters
  • IDWeekposter4.pdf (519.7 kB)
    • 1043
    Educational interventions increase Hepatitis C virus ( HCV) screening among pregnant women in inner city hospital
    Nitin Kumar, MD ; Dennis Super, MD ; Amy Edwards, MD ; Marwan Ali, B.S. ; Nazha Abughali, MD
    1044
    Identifying barriers and potential strategies to improve HCC surveillance for HBV-infected veterans
    Charitha Gowda, MD ; Umar Sheikh, MD ; Andrew Maier, MD ; David Kaplan, MD, MSc ; Kyong-Mi Chang, MD ; Vincent Lo Re III, MD, MSCE ; Valerianna Amorosa, MD
    Posters
  • HepB-HCC Poster (IDWeek2015).pdf (352.0 kB)
    • 1045
    Community-based Hepatitis B Screening, Vaccination, and Linkage to Care of Foreign-born Persons Residing in the United States, Philadelphia and Seattle, May 2012–May 2013
    Kiren Mitruka, MD, MPH ; Brittney Baack, MPH ; Chari Cohen, MPH ; Kim Nguyen, MSW ; Michael Ninburg, MA ; Kathy Byrd, MD, MPH
    1047
    Factors Affecting Mortality in Hepatitis with pregnancy - A Study from North India
    Niharika Yedla, MBBS ; Nikita Banerjee, MD ; Reva Tripathi, MD ; Bratati Banerjee, MD
    1048
    Hepatitis E Virus Genotype 3 in Solid Organ Transplant Recipients; Occurrence and the Option of Ribavirin Treatment
    Annelies Riezebos-Brilman, MD, PhD ; H. Blokzijl, MD, PhD ; Jan-Stephan Sanders, MD, PhD ; Erik Verschuuren, MD, PhD ; Bert Niesters, PhD
    Posters
  • Poster IDweek HEV def.pdf (185.7 kB)
    • 1049
    Hepatitis A Virus Infection Among Travelers –– Tulum, Mexico, 2015
    Monique Foster, MD, MPH ; Melissa Collier, MD, MPH ; Kathryn Spruit-Mcgoff, MSN ; Vasudha Reddy, MPH ; Jaclyn Skidmore, MSc ; Maureen Fonseca-Ford, MPH ; Elsa Villarino, MD, MPH

    CME Credits:

    ACPE Credits:

    ACPE Number:


    See more of: Poster Abstract Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.